Dysmorphic syndrome due to mucopolysaccharidosis type I

被引：0
|
作者：
Mounach, J. [1 ]
Abilkassem, R. [2 ]
Satte, A. [1 ]
Ouahmane, Y. [1 ]
Berri, M. Ait [1 ]
Agadr, A. [2 ]
Ouhabi, H. [1 ]
Zerhouni, A. [1 ]
机构：
[1] Hop Mil Instruct Mohammed V, Serv Neurophysiol, Rabat, Morocco
[2] Hop Mil Instruct Mohammed V, Serv Pediat, Rabat, Morocco
来源：
ARCHIVES DE PEDIATRIE | 2014年 / 21卷 / 04期
关键词：
ENZYME REPLACEMENT THERAPY;
D O I：
10.1016/j.arcped.2014.01.006
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
[No abstract available]
引用
收藏
页码：415 / 417
页数：3
相关论文
共 50 条
  • [21] Childhood onset of Scheie syndrome, the attenuated form of mucopolysaccharidosis I
    Thomas, Janet A.
    Beck, Michael
    Clarke, Joe T. R.
    Cox, Gerald F.
    JOURNAL OF INHERITED METABOLIC DISEASE, 2010, 33 (04) : 421 - 427
  • [22] Mucopolysaccharidosis Type II (Hunter Syndrome): Clinical Picture and Treatment
    Beck, Michael
    CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2011, 12 (06) : 861 - 866
  • [23] Mucopolysaccharidosis Type I: A Review of the Natural History and Molecular Pathology
    Hampe, Christiane S.
    Eisengart, Julie B.
    Lund, Troy C.
    Orchard, Paul J.
    Swietlicka, Monika
    Wesley, Jacob
    McIvor, R. Scott
    CELLS, 2020, 9 (08)
  • [24] Mucopolysaccharidosis Type I: Current Treatments, Limitations, and Prospects for Improvement
    Hampe, Christiane S.
    Wesley, Jacob
    Lund, Troy C.
    Orchard, Paul J.
    Polgreen, Lynda E.
    Eisengart, Julie B.
    McLoon, Linda K.
    Cureoglu, Sebahattin
    Schachern, Patricia
    McIvor, R. Scott
    BIOMOLECULES, 2021, 11 (02) : 1 - 25
  • [25] A pilot newborn screening program for Mucopolysaccharidosis type I in Taiwan
    Lin, Shuan-Pei
    Lin, Hsiang-Yu
    Wang, Tuen-Jen
    Chang, Chia-Ying
    Lin, Chia-Hui
    Huang, Sung-Fa
    Tsai, Chia-Chen
    Liu, Hsuan-Liang
    Keutzer, Joan
    Chuang, Chih-Kuang
    ORPHANET JOURNAL OF RARE DISEASES, 2013, 8
  • [26] Mucopolysaccharidosis Type III (Sanfilippo Syndrome): Emerging Treatment Strategies
    de Ruijter, J.
    Valstar, M. J.
    Wijburg, F. A.
    CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2011, 12 (06) : 923 - 930
  • [27] Case Report: Cerebral Revascularization in a Child With Mucopolysaccharidosis Type I
    Grant, Nathan
    Taylor, J. Michael
    Plummer, Zach
    Myers, Kasiani
    Burrow, Thomas
    Luchtman-Jones, Lori
    Byars, Anna
    Hammill, Adrienne
    Wusick, Katie
    Smith, Edward
    Leach, James
    Vadivelu, Sudhakar
    FRONTIERS IN PEDIATRICS, 2021, 9
  • [28] Laronidase (Aldurazyme®):: enzyme replacement therapy for mucopolysaccharidosis type I
    Pastores, Gregory M.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2008, 8 (07) : 1003 - 1009
  • [29] Diagnosis and Management of Mucopolysaccharidosis Type II (Hunter Syndrome) in Poland
    Zuber, Zbigniew
    Kiec-Wilk, Beata
    Kaluzny, Lukasz
    Wierzba, Jolanta
    Tylki-Szymanska, Anna
    BIOMEDICINES, 2023, 11 (06)
  • [30] Mucopolysaccharidosis type I: current knowledge on its pathophysiological mechanisms
    Campos, Derbis
    Monaga, Madelyn
    METABOLIC BRAIN DISEASE, 2012, 27 (02) : 121 - 129
12345